Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, Bergen County, New Jersey, United States, with off-site locations throughout Bergen, Hudson, and Passaic counties.

There are 361 beds in Holy Name Medical Center.

During the past decade, Holy Name Medical Center conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 43 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 31 clinical trials were completed. i.e. 77.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Name Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Holy Name Medical Center, Inc." with 4 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Name Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 3 trials as a collaborator and "GOG Foundation" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Holy Name Medical Center" are "Critical Limb Ischemia" (8 trials), "Fallopian Tube Cancer" (7 trials), "Peripheral Arterial Disease" (7 trials), "Multiple Sclerosis" (6 trials) and "Crohn's Disease" (5 trials). Many other conditions were trialed in "Holy Name Medical Center" in a lesser frequency.

Most popular intervention types in "Holy Name Medical Center" are "Drug" (71 trials), "Device" (30 trials), "Other" (25 trials), "Biological" (18 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Paclitaxel" (11 trials), "Quality-of-Life Assessment" (7 trials), "Carboplatin" (6 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Holy Name Medical Center" are 103 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Holy Name Medical Center". undefined are not yet recruiting, 25 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Holy Name Medical Center, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Name Medical Center, 0 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 24 trials that are defined as “Not Applicable".